The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients’ sex - Wang, Shixiang; Zhang, Jing; He, Zaoke; Wu, Kai; Liu, Xue‐Song (International journal of cancer, 2019)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological - pharmacology; Antineoplastic Agents, Immunological - therapeutic use; B7-H1 Antigen - antagonists & inhibitors; B7-H1 Antigen - metabolism; Biomarkers; Cancer; Cancer immunotherapy; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - mortality; Datasets as Topic; DNA Mutational Analysis; Female; Gender differences; Humans; Immune checkpoint inhibitors; Immunotherapy; Kaplan-Meier Estimate; Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - mortality; Male; Medical research; Middle Aged; Mutation Rate; PD-L1 protein; Predictive Value of Tests; Prognosis; Progression-Free Survival; ROC Curve; Sex differences; Sex Factors; Time Factors; tumor mutational burden; Whole Exome Sequencing; Young Adult; lung cancer; immune checkpoint inhibitors; tumor mutational burden; sex differences; cancer immunotherapy